• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炭疽芽孢杆菌A类和B类β-内酰胺酶的基于青霉素的抑制剂的评估。

Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis.

作者信息

Beharry Zanna, Chen Hansong, Gadhachanda Venkat R, Buynak John D, Palzkill Timothy

机构信息

Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

出版信息

Biochem Biophys Res Commun. 2004 Jan 16;313(3):541-5. doi: 10.1016/j.bbrc.2003.11.158.

DOI:10.1016/j.bbrc.2003.11.158
PMID:14697223
Abstract

Bacillus anthracis contains a class A (Bla1) and class B (Bla2) beta-lactamase, which confer resistance to beta-lactam antibiotics when expressed in Escherichia coli. In an effort to find new beta-lactamase inhibitors, several penicillin derivatives have been evaluated including experimental compounds incorporating a 6-mercaptomethyl group or a 6-pyridylmethylidene group, along with clavulanate and tazobactam, as inhibitors against Bla1 and Bla2. The 6-mercaptomethyl-substituted penicillins showed much greater activity against the zinc-containing Bla2 than Bla1. The compound that incorporated a 6-pyridylmethylidene substituent and a catecholic substituent at the 2' position was the most effective inhibitor of Bla1 with Ki=0.057 microM. Inhibitors containing iron-chelating functional groups have previously been shown to work in combination with antibiotics to inhibit growth of antibiotic-resistant bacteria expressing beta-lactamase. The development of similar compounds, incorporating these types of substituents, may help overcome resistance to currently used antibiotics.

摘要

炭疽芽孢杆菌含有A类(Bla1)和B类(Bla2)β-内酰胺酶,当它们在大肠杆菌中表达时可赋予对β-内酰胺抗生素的抗性。为了寻找新的β-内酰胺酶抑制剂,已对几种青霉素衍生物进行了评估,包括含有6-巯基甲基基团或6-吡啶基亚甲基基团的实验性化合物,以及克拉维酸和他唑巴坦,作为针对Bla1和Bla2的抑制剂。6-巯基甲基取代的青霉素对含锌的Bla2的活性比对Bla1的活性高得多。在2'位含有6-吡啶基亚甲基取代基和儿茶酚取代基的化合物是最有效的Bla1抑制剂,其Ki = 0.057 microM。先前已证明含有铁螯合官能团的抑制剂可与抗生素联合使用,以抑制表达β-内酰胺酶的耐抗生素细菌的生长。开发含有这些类型取代基的类似化合物可能有助于克服对目前使用的抗生素的耐药性。

相似文献

1
Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis.炭疽芽孢杆菌A类和B类β-内酰胺酶的基于青霉素的抑制剂的评估。
Biochem Biophys Res Commun. 2004 Jan 16;313(3):541-5. doi: 10.1016/j.bbrc.2003.11.158.
2
Beta-lactamase genes of the penicillin-susceptible Bacillus anthracis Sterne strain.青霉素敏感型炭疽芽孢杆菌Sterne菌株的β-内酰胺酶基因
J Bacteriol. 2003 Feb;185(3):823-30. doi: 10.1128/JB.185.3.823-830.2003.
3
Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.他唑巴坦是一种对特定的耐抑制剂A类β-内酰胺酶有效的抑制剂。
FEMS Microbiol Lett. 1997 Mar 1;148(1):59-62. doi: 10.1111/j.1574-6968.1997.tb10267.x.
4
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.了解SHVβ-内酰胺酶对β-内酰胺类和β-内酰胺酶抑制剂的耐药性:丝氨酸130诱变的启示
J Biol Chem. 2003 Dec 26;278(52):52724-9. doi: 10.1074/jbc.M306059200. Epub 2003 Oct 8.
5
An extracytoplasmic function sigma factor controls beta-lactamase gene expression in Bacillus anthracis and other Bacillus cereus group species.一种胞质外功能σ因子控制炭疽芽孢杆菌及其他蜡样芽孢杆菌群物种中β-内酰胺酶基因的表达。
J Bacteriol. 2009 Nov;191(21):6683-93. doi: 10.1128/JB.00691-09. Epub 2009 Aug 28.
6
Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.炭疽芽孢杆菌β-内酰胺酶Bla1和Bla2的生化特性
Antimicrob Agents Chemother. 2003 Jun;47(6):2040-2. doi: 10.1128/AAC.47.6.2040-2042.2003.
7
An insight into the complete biophysical and biochemical characterization of novel class A beta-lactamase (Bla1) from Bacillus anthracis.深入了解炭疽芽孢杆菌新型 A 类β-内酰胺酶(Bla1)的完整物理化学和生物化学特性。
Int J Biol Macromol. 2020 Feb 15;145:510-526. doi: 10.1016/j.ijbiomac.2019.12.136. Epub 2019 Dec 23.
8
Purification development and characterization of the zinc-dependent metallo-β-lactamase from Bacillus anthracis.从炭疽芽孢杆菌中纯化、开发和表征锌依赖性金属β-内酰胺酶。
Biotechnol Lett. 2011 Jul;33(7):1417-22. doi: 10.1007/s10529-011-0569-9. Epub 2011 Mar 3.
9
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.天冬氨酸替代276位的天冬酰胺会降低SHV-1和SHV-5β-内酰胺酶对基于机制的抑制剂的敏感性。
J Antimicrob Chemother. 1999 Jan;43(1):23-9. doi: 10.1093/jac/43.1.23.
10
Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.SHV家族A类酶OHIO-1β-内酰胺酶的一种抑制剂抗性变体的动力学分析。
Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):395-400. doi: 10.1042/bj3330395.

引用本文的文献

1
Development of Hydroxamic Acid Compounds for Inhibition of Metallo-β-Lactamase from .用于抑制金属β-内酰胺酶的羟肟酸类化合物的开发。
Int J Mol Sci. 2022 Aug 15;23(16):9163. doi: 10.3390/ijms23169163.
2
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.金属β-内酰胺酶的多样性和增殖:呼吁开发临床上有效的金属β-内酰胺酶抑制剂。
Appl Environ Microbiol. 2018 Aug 31;84(18). doi: 10.1128/AEM.00698-18. Print 2018 Sep 15.
3
An Update on the Status of Potent Inhibitors of Metallo-β-Lactamases.
金属β-内酰胺酶强效抑制剂的现状更新
Sci Pharm. 2013 Apr-Jun;81(2):309-27. doi: 10.3797/scipharm.1302-08. Epub 2013 Mar 28.
4
Structures of SHV-1 β-lactamase with penem and penam sulfone inhibitors that form cyclic intermediates stabilized by carbonyl conjugation.与碳基共轭稳定的环中间体形成的碳青霉烯和青霉烯砜抑制剂与 SHV-1 β-内酰胺酶的结构。
PLoS One. 2012;7(11):e49035. doi: 10.1371/journal.pone.0049035. Epub 2012 Nov 8.
5
Antibodies against anthrax: mechanisms of action and clinical applications.抗炭疽抗体:作用机制与临床应用。
Toxins (Basel). 2011 Nov;3(11):1433-52. doi: 10.3390/toxins3111433. Epub 2011 Nov 16.
6
PheMaDB: a solution for storage, retrieval, and analysis of high throughput phenotype data.PheMaDB:一种用于存储、检索和分析高通量表型数据的解决方案。
BMC Bioinformatics. 2011 Apr 20;12:109. doi: 10.1186/1471-2105-12-109.
7
Current challenges in antimicrobial chemotherapy: focus on ß-lactamase inhibition.当前抗菌药物化疗的挑战:聚焦β-内酰胺酶抑制。
Drugs. 2010 Apr 16;70(6):651-79. doi: 10.2165/11318430-000000000-00000.
8
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model.法罗培南在致命性炭疽杆菌吸入性暴露后预防模型中的药代动力学-药效学评估。
Antimicrob Agents Chemother. 2010 May;54(5):1678-83. doi: 10.1128/AAC.00737-08. Epub 2010 Feb 9.
9
Penicillin sulfone inhibitors of class D beta-lactamases.D 类β-内酰胺酶的青霉素砜抑制剂。
Antimicrob Agents Chemother. 2010 Apr;54(4):1414-24. doi: 10.1128/AAC.00743-09. Epub 2010 Jan 19.
10
Morphogen-defined patterning of Escherichia coli enabled by an externally tunable band-pass filter.通过外部可调带通滤波器实现大肠杆菌的形态发生图案。
J Biol Eng. 2009 Jul 8;3:10. doi: 10.1186/1754-1611-3-10.